Prophylactic dexamethasone for prevention of opioid-induced nausea and vomiting in cancer patients: a randomised controlled trial (DEX-OINV Trial)
A randomised controlled trial finds that prophylactic dexamethasone is associated with reduced nausea severity in opioid-naïve cancer patients starting oral ...










